Lut Janssen

463 total citations
4 papers, 132 citations indexed

About

Lut Janssen is a scholar working on Molecular Biology, Oncology and Biophysics. According to data from OpenAlex, Lut Janssen has authored 4 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Biophysics. Recurrent topics in Lut Janssen's work include Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (2 papers) and Signaling Pathways in Disease (1 paper). Lut Janssen is often cited by papers focused on Histone Deacetylase Inhibitors Research (3 papers), Protein Degradation and Inhibitors (2 papers) and Signaling Pathways in Disease (1 paper). Lut Janssen collaborates with scholars based in Belgium, Germany and United States. Lut Janssen's co-authors include Janine Arts, Kristof Van Emelen, Patrick Angibaud, P King, Dana L. Johnson, Luc Andries, Jacky Van Dun, Michel Janicot, Wim Floren and Robert W. Tuman and has published in prestigious journals such as Cancer Research, British Journal of Cancer and SLAS DISCOVERY.

In The Last Decade

Lut Janssen

4 papers receiving 126 citations

Peers

Lut Janssen
Benjamin A. Turner United States
Amit Kapadia United States
Brian Juba United States
Jane Wei United States
Jeremy To United States
Benjamin A. Turner United States
Lut Janssen
Citations per year, relative to Lut Janssen Lut Janssen (= 1×) peers Benjamin A. Turner

Countries citing papers authored by Lut Janssen

Since Specialization
Citations

This map shows the geographic impact of Lut Janssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lut Janssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lut Janssen more than expected).

Fields of papers citing papers by Lut Janssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lut Janssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lut Janssen. The network helps show where Lut Janssen may publish in the future.

Co-authorship network of co-authors of Lut Janssen

This figure shows the co-authorship network connecting the top 25 collaborators of Lut Janssen. A scholar is included among the top collaborators of Lut Janssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lut Janssen. Lut Janssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Krausz, Eberhard, Ronald De Hoogt, Emmanuel Gustin, et al.. (2012). Translation of a Tumor Microenvironment Mimicking 3D Tumor Growth Co-culture Assay Platform to High-Content Screening. SLAS DISCOVERY. 18(1). 54–66. 52 indexed citations
2.
Hickson, Ian, Peter King, Lut Janssen, et al.. (2010). Abstract 5441: Preclinical assessment of the HDAC inhibitor JNJ-26481585: potent in vivo activity across a broad spectrum of human tumor xenografts. Cancer Research. 70(8_Supplement). 5441–5441. 1 indexed citations
3.
Arts, Janine, Patrick Angibaud, Wim Floren, et al.. (2007). R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. British Journal of Cancer. 97(10). 1344–1353. 77 indexed citations
4.
Arts, Janine, Peter King, Wim Floren, et al.. (2007). JNJ-26481585, a novel “second-generation” oral pan-histone deacetylase (HDAC) inhibitor, shows broad-spectrum preclinical antitumoral activity against solid and hematological malignancies. FreiDok plus (Universitätsbibliothek Freiburg). 6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026